A Observational Study to Evaluate Deucravacitinib in Patients With Moderate Plaque Psoriasis in China
Clinical trial NCT06512337 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06512337
- Sponsor
- Bristol-Myers Squibb
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-01-20
- Primary completion
- 2027-03-11
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.